Juliana Batista da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juliana Batista da Silva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Mamede
Department of Anatomy and Imaging, School of Medicine, Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte
3 shared publications - Ana Carolina De Araujo Bispo
Centro de Desenvolvimento da Tecnologia Nuclear
2 shared publications - Andréa Vidal Ferreira
Centro de Desenvolvimento da Tecnologia Nuclear
2 shared publications Ana Clara Ferreira Castro
1 shared publication- Bruno Melo Mendes
Centro de Desenvolvimento da Tecnologia Nuclear
1 shared publication - Cassiano Lino dos Santos Costa
Radiopharmaceutical Production and Development Unit, Nuclear Technology Development Center, Av. Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG, Brazil
1 shared publication
Latest Publications
- Open Access
- 20 December 2022
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 10 (4) , 1-12
18F-FES radiation dosimetry preliminary estimates for preclinical studies based on voxelized phantom
Small animals, such as mice, are used in radiopharmaceutical biodistribution studies and innumerous others preclinical investigations involving ionizing radiation. Longitudinal preclinical studies with five or more image procedures, involving radiopharmaceuticals injection and/or X-radiation, are not uncommon. However, a suitable dosimetric evaluation is not always available and, sometimes, absorbed doses in animal organs or tissues and their influence in experimental results were not appropriately taken into account. Accurate calculation of absorbed doses in mice organs are needed to evaluate potential radiobiological effects that may interfere with in vivo experiments. In this work, we perform a preliminary 16α-[18F]-fluoro-17β-estradiol (18F-FES) radiation dosimetry estimates for female mice. The obtained animal dosimetric results can be useful for evaluating animal doses during the design of longitudinal preclinical studies.
- 20 December 2022
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 10 (4) , 1-12
Open Access18F-FES radiation dosimetry preliminary estimates for preclinical studies based on voxelized phantom
Small animals, such as mice, are used in radiopharmaceutical biodistribution studies and innumerous others preclinical investigations involving ionizing radiation. Longitudinal preclinical studies with five or more image procedures, involving radiopharmaceuticals injection and/or X-radiation, are not uncommon. However, a suitable dosimetric evaluation is not always available and, sometimes, absorbed doses in animal organs or tissues and their influence in experimental results were not appropriately taken into account. Accurate calculation of absorbed doses in mice organs are needed to evaluate potential radiobiological effects that may interfere with in vivo experiments. In this work, we perform a preliminary 16α-[18F]-fluoro-17β-estradiol (18F-FES) radiation dosimetry estimates for female mice. The obtained animal dosimetric results can be useful for evaluating animal doses during the design of longitudinal preclinical studies.
- Open Access
- 30 April 2021
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 9 (1A)
Spatial resolution of a preclinical PET tomograph
Positron emission tomography (PET) is an important molecular image modality and its application on preclinical research has increased during last decades. Thus, in laboratory practice, it is important to implement a quality control of the equipment, since intrinsic factors influence the image quality. The objective of this work was to perform and implement spatial resolution tests for the small animal PET scanner of the Molecular Imaging Laboratory, LIM/CDTN. Empirically, spatial resolution of a PET scanner can be determined from the measurement of point or linear sources and FWHM (full width half maximum) analysis of the respective linear profiles. In this work, a point source of 22Na and a hot rod style phantom filled with 18F-FDG solution were used. Acquisition and reconstruction of images were performed with the LabPET 1.12.1 software, provided by the equipment manufacturer. Image reconstruction parameters followed the LIM standard protocol: MLEM-3D algorithm, 20 iterations, no high resolution mode, no attenuation or scatter corrections, no post-filtering. PeakFit® and Amide softwares were used to perform images post-processing. The results indicate that the scanner has an adequate spatial resolution and its value is compatible with values reported in international studies performed on similar equipments.
- 30 April 2021
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 9 (1A)
Open AccessSpatial resolution of a preclinical PET tomograph
Positron emission tomography (PET) is an important molecular image modality and its application on preclinical research has increased during last decades. Thus, in laboratory practice, it is important to implement a quality control of the equipment, since intrinsic factors influence the image quality. The objective of this work was to perform and implement spatial resolution tests for the small animal PET scanner of the Molecular Imaging Laboratory, LIM/CDTN. Empirically, spatial resolution of a PET scanner can be determined from the measurement of point or linear sources and FWHM (full width half maximum) analysis of the respective linear profiles. In this work, a point source of 22Na and a hot rod style phantom filled with 18F-FDG solution were used. Acquisition and reconstruction of images were performed with the LabPET 1.12.1 software, provided by the equipment manufacturer. Image reconstruction parameters followed the LIM standard protocol: MLEM-3D algorithm, 20 iterations, no high resolution mode, no attenuation or scatter corrections, no post-filtering. PeakFit® and Amide softwares were used to perform images post-processing. The results indicate that the scanner has an adequate spatial resolution and its value is compatible with values reported in international studies performed on similar equipments.
- Open Access
- 30 April 2021
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 9 (1A)
Synthesis and characterization of the radiopharmaceutical [18F]fluoroestradiol
[18F]Fluoroestradiol ([18F]FES), an estrogen analog, may be used in Positron Emission Tomography (PET) for evaluation of the tumor cell receptor profile in a noninvasive way, which is an important factor for determining the therapy to be used, disease staging, prognosis and response to therapy in breast cancer. [18F]FES is a new radiopharmaceutical and does not have an official monograph in any pharmacopeia until now. Therefore, the objective of this work was the optimization of the [18F]FES automatic synthesis and the elaboration of an analytical protocol for final product analyses. Initially, the synthesis of [18F]FES was performed according to a modified commercial protocol, using a TracerLab MXFDG synthesis module specific for [18F]FES synthesis. New protocols for the physicochemical quality control assays of the radiopharmaceutical were developed, including pH, chemical purity, residual solvents, radiochemical identity and purity. Physicochemical and microbiological analysis were performed with the synthesized [18F]FES at different time points to evaluate its stability. The uncorrected synthesis yield was 18.37 ± 3.07 %. All Quality Control methodologies proved to be effective for the product. The physicochemical and microbiological results obtained in the stability study showed that [18F]FES is stable during 8 hours after its synthesis, even under stress conditions. At the end of the study, it was concluded that the [18F]FES complies with all specifications required for a radiopharmaceutical intended for diagnostic use.
- 30 April 2021
- Published by Sociedade Brasileira de Proteção Radiológica - SBPR in Brazilian Journal of Radiation Sciences
- Vol. 9 (1A)
Open AccessSynthesis and characterization of the radiopharmaceutical [18F]fluoroestradiol
[18F]Fluoroestradiol ([18F]FES), an estrogen analog, may be used in Positron Emission Tomography (PET) for evaluation of the tumor cell receptor profile in a noninvasive way, which is an important factor for determining the therapy to be used, disease staging, prognosis and response to therapy in breast cancer. [18F]FES is a new radiopharmaceutical and does not have an official monograph in any pharmacopeia until now. Therefore, the objective of this work was the optimization of the [18F]FES automatic synthesis and the elaboration of an analytical protocol for final product analyses. Initially, the synthesis of [18F]FES was performed according to a modified commercial protocol, using a TracerLab MXFDG synthesis module specific for [18F]FES synthesis. New protocols for the physicochemical quality control assays of the radiopharmaceutical were developed, including pH, chemical purity, residual solvents, radiochemical identity and purity. Physicochemical and microbiological analysis were performed with the synthesized [18F]FES at different time points to evaluate its stability. The uncorrected synthesis yield was 18.37 ± 3.07 %. All Quality Control methodologies proved to be effective for the product. The physicochemical and microbiological results obtained in the stability study showed that [18F]FES is stable during 8 hours after its synthesis, even under stress conditions. At the end of the study, it was concluded that the [18F]FES complies with all specifications required for a radiopharmaceutical intended for diagnostic use.
- 1 June 2019
- Published by Elsevier in Microchemical Journal
- Vol. 147, 654-659
Multivariate optimization and validation of a procedure to direct determine acetonitrile and ethanol in radiopharmaceuticals by GC-FID
- 1 June 2019
- Published by Elsevier in Microchemical Journal
- Vol. 147, 654-659
Multivariate optimization and validation of a procedure to direct determine acetonitrile and ethanol in radiopharmaceuticals by GC-FID